• 24 November 2015
  • Interviews
  • By Ayesha

Bangalore is our very precious office in Asia: Dr Emmanuelle Voisin

BioSpectrum caught up with Dr Emmanuelle Voisin, founder, Voisin Consulting Life Sciences and Dr Rajashree Devarakonda, vice-president, India and Asia Pacific Operations, to discuss about VCLS’ operations, the kinds of services the company offer, and


Please introduce Voisin Consulting Life Sciences.

Dr Emmanuelle Voisin: Voisin Consulting Life Sciences (VCLS), was started in 1997 in order to assist the Pharma, Biotech and MedTech industry, especially the start-ups at that time, to place their products in the market. It is basically a product development and regulatory strategy consulting firm.

Over the years, the firm have evolved along two different areas. One, is we are regulatory driven, that is when a new regulation is been sought by the EC (European Commission) or US FDA (United States Food and Drug Administration) we are present and we try to understand the philosophy behind the regulations and prepare the services accordingly. So basically being regulatory driven means that when there is an orphan regulation in the air, be it orphan, pediatric etc, we know exactly what's going on and prepare the kind of services that our client will need. We once prepared for the geriatric regulation that never came up, but that's okay we are always prepared for everything and well ahead of time.

The number two is geography driven we really wanted to be an international firm and not just a network of consultants across the world. We are all employees in the different companies in different parts of the world. Europe is represented by France (Paris and Rennes), UK, and Switzerland. USA is represented by two main offices in Cambridge and San Francisco with more offices planed on the east coast, and of course Bangalore is our only and very important office in APAC.

What was the rationale behind setting up an office in India?

Previous 1 3 4 5 6 7 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email